Tribunal classifies products as ayurvedic medicaments, not cosmetics under Central Excise Tariff Act.

The appellate tribunal upheld the classification of products as ayurvedic medicaments rather than cosmetic preparations under the Central Excise Tariff Act. The tribunal found that the goods were supported by clinical studies and certificates from medical practitioners, indicating their medicinal value against ring worms. As the Revenue failed to successfully classify the goods as cosmetic preparations and did not contest the evidence presented by the respondent, the tribunal concluded in favor of classification as ayurvedic medicaments. The exemption issue based on brand name usage was not addressed as the classification issue was resolved in favor of the assessee, resulting in the dismissal of the appeal.

---

---

Issues:
Classification of products as ayurvedic medicaments or cosmetic preparations under Central Excise Tariff Act; Exemption from payment of duty based on brand name usage.

Classification Issue Analysis:
The appeal concerns the classification of products as ayurvedic medicaments or cosmetic preparations under the Central Excise Tariff Act. The Revenue argues for classification under heading 33.04 as cosmetic preparations, emphasizing that the products were marketed for skin care and did not require a medical prescription. They rely on a chemical test report stating the products were talcum powder for skin care. However, the lower appellate authority considered evidence provided by the assessee, including clinical studies and certificates from medical practitioners, to support the medicinal value of the products. The authority found that the goods were ayurvedic medicaments used against ring worms, supported by documents like clinical reports and certificates. The appellate tribunal upheld this finding, noting that the Revenue failed to successfully classify the goods under heading 33.04 and did not contest the evidentiary value of the documents presented by the respondent. Therefore, the tribunal concluded that the products should be classified as ayurvedic medicaments.

Exemption Issue Analysis:
Regarding the exemption from duty based on brand name usage, the Revenue argued that the brand name 'LEXUS' was sold to another entity during a specific period, making the claim for exemption invalid. However, the tribunal did not delve into this issue as the classification of the products was already determined in favor of the assessee. Therefore, the tribunal sustained the lower appellate authority's decision on the classification issue, leading to the dismissal of the appeal.

---